Karen Dawes named co-chair of Repligen
This article was originally published in Scrip
Repligen has elected Karen Dawes co-chairperson of the board of directors, serving alongside Dr Alexander Rich. MS Dawes has been a director of Repligen since September 2005. Her previous positions include senior vice-president and US business group head for Bayer, senior vice-president of global strategic marketing for Wyeth and vice-president of marketing of Pfizer's Pratt Division.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.